Jeremy Y.C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM

Chinese University of Hong Kong

Hong Kong (China)

Dr. Jeremy Teoh is an Assistant Professor of Surgery at the Chinese University of Hong Kong. His primary areas of interest are prostate cancer and bladder cancer. He has published extensively on the adverse events related to androgen deprivation therapy, specifically from an Asian perspective. He is also a pioneer in Asia of transurethral en bloc resection of bladder tumors. He has published more than 100 articles in peer-reviewed journals, as well as 5 book chapters. He currently serves as the Director of the Lions Kidney Educational Centre and Research Foundation, as a faculty member of the Asian Urological Surgery Training & Education Group, and as a member of the Asian Robot-Assisted Radical Cystectomy Consortium.

Talks by Jeremy Y.C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM

The Cardiovascular Effects of Orchiectomy Versus LHRH Agonists

Jeremy Y.C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM | Feb 2020

Jeremy Y.C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM, Assistant Professor at the Chinese University of Hong Kong, outlines the increased risk of cardiovascular events associated with patients undergoing bilateral orchiectomy compared to patients treated instead with luteinizing hormone-releasing hormone (LHRH) agonists or antagonists. He discusses an important study that confirmed the increase in these events for men undergoing orchiectomy.